These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 3885723
1. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. Fitscha P, Kaliman J, Sinzinger H. Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723 [Abstract] [Full Text] [Related]
2. Value of platelet sensitivity to antiaggregatory prostaglandins (PGI2, PGE1, PGD2) in 50 patients with myocardial infarction at young age. Sinzinger H, Kaliman J, Widhalm K, Pachinger O, Probst P. Prostaglandins Med; 1981 Aug; 7(2):125-32. PubMed ID: 7025071 [Abstract] [Full Text] [Related]
3. Sensitivity of platelets to prostaglandins in cornary heart disease and angina pectoris. Sinzinger H, Schernthaner G, Kaliman J. Prostaglandins; 1981 Nov; 22(5):773-81. PubMed ID: 7036225 [Abstract] [Full Text] [Related]
4. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1). Nakagawa S, Matsui N, Akiba T, Shinoda T, Fukudome Y, Ozawa K, Baba M, Nakanishi T, Takeuchi J. Proc Eur Dial Transplant Assoc; 1981 Nov; 18():117-21. PubMed ID: 7036145 [Abstract] [Full Text] [Related]
7. Prostaglandins as inhibitors of human platelet aggregation. Di Minno G, Silver MJ, de Gaetano G. Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296 [Abstract] [Full Text] [Related]
9. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Whittle BJ, Moncada S, Vane JR. Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545 [Abstract] [Full Text] [Related]
10. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent. Miller OV, Aiken JW, Shebuski RJ, Gorman RR. Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513 [Abstract] [Full Text] [Related]
11. Influences of prostaglandins on electrophoretic mobility and aggregation of rabbit platelets. Takano S, Itagaki S, Sakurai K, Suzuki T. Prostaglandins; 1980 Sep; 20(3):579-86. PubMed ID: 6999547 [Abstract] [Full Text] [Related]
12. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life. Strobl-Jäger E, Widhalm K, Sinzinger H. Prostaglandins Leukot Med; 1986 Nov; 25(1):39-47. PubMed ID: 3540998 [Abstract] [Full Text] [Related]
13. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Ashby B. Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318 [Abstract] [Full Text] [Related]
14. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. Fortini A, Modesti PA, Abbate R, Gensini GF, Neri Serneri GG. Thromb Res; 1985 Nov 01; 40(3):319-28. PubMed ID: 3001968 [Abstract] [Full Text] [Related]
17. The intrainfusion platelet rebound during and following PGE1-infusion is faster and more intensive than that with PGI2. Sinzinger H, Reiter S. Prostaglandins Leukot Med; 1984 Mar 01; 13(3):281-8. PubMed ID: 6585847 [Abstract] [Full Text] [Related]